Equinor ASA (EQNR)

Capital Expenditure

-$2.87B

Quarterly · Period ending: · USD

EQNR logo

EQNR Capital Expenditure

Latest reported-$2.87B
EQNR Quarterly CapEx (-$196.00M → -$2.87B)
High-resolution chart · PNG

EQNR capital expenditure history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Equinor ASA Capital Expenditure — Quarterly (USD)
Period endingCapital Expenditure (USD)
-2,872,000,000
-3,116,000,000
-4,145,962,443
-3,420,245,000
-3,444,176,000
-3,027,000,000
-3,646,000,000
-3,098,000,000
-2,950,000,000
-2,483,000,000
-3,030,000,000
-2,652,000,000
-2,842,000,000
-2,303,000,000
-2,376,000,000
-2,053,000,000
-1,713,000,000
-2,182,000,000
-2,337,000,000
-1,964,000,000
-1,747,000,000
-2,151,000,000
-2,504,000,000
-1,723,000,000
-1,899,000,000
-2,350,000,000
-2,700,000,000
-2,637,000,000
-2,834,000,000
-2,033,000,000
-2,990,000,000
-3,073,000,000
-2,774,000,000
-2,377,000,000
-3,398,000,000
-2,634,000,000
-2,346,000,000
-2,377,000,000
-3,819,000,000
-2,656,000,000
-2,896,000,000
-2,821,000,000
-3,117,022,584
-3,858,598,302
-4,296,657,506
-3,828,966,192
-4,452,018,405
-4,018,126,560
-5,316,407,804
-4,778,833,265
-4,647,266,308
-4,144,853,474
-5,118,751,749
-4,698,645,936
-5,781,001,038
-5,358,661,172
-3,747,788,420
-5,244,517,646
-4,543,667,253
-3,575,523,805
-3,903,839,037
-3,428,484,447
-3,621,398,135
-3,810,420,403
-2,563,298,320
-3,320,129,191
-3,047,435,819
-3,776,426,146
-3,068,301,335
-2,938,836,105
-3,039,000,000
-1,648,000,000
-2,848,000,000
-2,432,000,000
-6,418,000,000
-2,798,000,000
-1,358,000,000
-2,492,000,000
-2,824,000,000
-1,389,000,000
-1,325,000,000
-1,189,000,000
891,000,000
-1,149,000,000
-3,212,000,000
-1,179,000,000
-1,602,000,000
-1,631,000,000
-1,240,000,000
-796,000,000
-1,008,000,000
-890,000,000
-725,000,000
-697,000,000
-876,000,000
-595,000,000
-665,000,000
-443,000,000
-577,000,000
-196,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.